EDGAR Filing Documents for 0001437749-17-001259

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001437749-17-001259

Filing Date

2017-01-27

Accepted

2017-01-27 17:29:15

Documents

101

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1/A	atrn20170125_s1a.htm	S-1/A	2506679
2	EXHIBIT 23.1	ex23-1.htm	EX-23.1	4081
3	EXHIBIT 23.2	ex23-2.htm	EX-23.2	5892
10		slogo.jpg	GRAPHIC	36078
11		schulman.jpg	GRAPHIC	376408
12		a1.jpg	GRAPHIC	15754
	Complete submission text file	0001437749-17-001259.txt		11210174

Data Files

Seq	Description	Document	Type	Size
4	EXHIBIT 101.INS	atrn-20160930.xml	EX-101.INS	1674437
5	EXHIBIT 101.SCH	atrn-20160930.xsd	EX-101.SCH	91932
6	EXHIBIT 101.CAL	atrn-20160930_cal.xml	EX-101.CAL	56665
7	EXHIBIT 101.DEF	atrn-20160930_def.xml	EX-101.DEF	814715
8	EXHIBIT 101.LAB	atrn-20160930_lab.xml	EX-101.LAB	434834
9	EXHIBIT 101.PRE	atrn-20160930_pre.xml	EX-101.PRE	826748

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010

Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200

Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)